Composti Organometallici
I composti organometallici sono sostanze che contengono legami tra atomi di carbonio e metalli, solitamente metalli di transizione come magnesio, zinco o platino. Questi composti presentano una grande diversità strutturale e chimica, conferendo loro un’elevata reattività. Sono principalmente utilizzati nella sintesi organica, catalizzando reazioni come la polimerizzazione dei monomeri e la formazione di legami carbonio-carbonio. Inoltre, i composti organometallici trovano applicazione nell’industria farmaceutica, ad esempio nella produzione di farmaci antitumorali, e nei processi industriali come la produzione di materie plastiche e combustibili.
Presso CymitQuimica, offriamo una vasta gamma di composti organometallici per la ricerca in chimica organica, catalisi e sintesi di nuovi materiali.
Trovati 4422 prodotti di "Composti Organometallici"
Ordinare per
Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
1,1-Cyclobutanedicarboxylic Acid
CAS:<p>Applications 1,1-Cyclobutanedicarboxylic Acid is used in the design, studies and structural model of antitumor dicycloplatin a clinical cancer drug. Hydrolysis mechanism of second-generation anticancer drug carboplatin.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Yang, X. Q., et al.: Science China: Chemistry, 53, 1346 (2010); Pavelka, M., et al.: Chem. Eur. J., 13, 10108 (2007)<br></p>Formula:C6H8O4Colore e forma:NeatPeso molecolare:144.13Transplatin
CAS:<p>Applications Transplatin is the trans stereoisomer impurity of Cisplatin (C499500), an antineoplastic used in the treatment of sarcomas, some carcinomas, lymphomas, and germ cell tumors. Transplatin binds to DNA but does not exhibit the same useful pharmacological effect as its cis stereoisomer.<br>References Cersosimo, R.J.: Cancer Treat. Rev., 16, 195 (1989); Takeiri, A. et al.: Genes Environ., 29, 89 (2007); Giraud-Panis, M.-J. et al.: Pharmacol. Therap., 85, 175 (2000);<br></p>Formula:Cl2H6N2PtColore e forma:Light YellowPeso molecolare:300.04{1-[(tert-Butoxy)carbonyl]-1,2,5,6-tetrahydropyridin-3-yl}boronic acid
CAS:Purezza:98%Peso molecolare:227.0700073Gadodiamide
CAS:Prodotto controllato<p>Applications Gadodiamide is an apoptosis inducing agent used in chondrocytes. It is primarily used in muscoskeletal diagnosis as a contrast agent.<br>References Greisberg, J. et al.: Mag. Res. Imag., 19, 731 (2001); Hemmingsson, A. et al.: Mag. Res. Mat. Phys. Biol. Med., 12, 96 (2001);<br></p>Formula:C16H26GdN5O8Colore e forma:NeatPeso molecolare:573.66(3-Methoxypyridin-4-yl)boronic acid hydrate
CAS:Formula:C6H10BNO4Purezza:95.0%Colore e forma:SolidPeso molecolare:170.963-(Methoxycarbonyl)thiophene-2-boronic acid
CAS:Purezza:95%Colore e forma:SolidPeso molecolare:185.99000549316406(4-Chloro-2-propoxyphenyl)boronic acid
CAS:Purezza:95.0%Colore e forma:SolidPeso molecolare:214.4499969482422Ref: 10-F603124
1gPrezzo su richiesta100mgPrezzo su richiesta250mgPrezzo su richiesta500mgPrezzo su richiesta4-Borono-2,6-difluorobenzoic acid
CAS:Formula:C7H5BF2O4Purezza:98%Colore e forma:No data available.Peso molecolare:201.923-Chloro-4-pyridineboronic acid hydrate
CAS:Formula:C5H7BClNO3Purezza:95.0%Colore e forma:SolidPeso molecolare:175.38Potassium Trichloroammineplatinate
CAS:Prodotto controllato<p>Applications Potassium Trichloroammineplatinate is the degradation product of Cisplatin (C499500), an antitumor compound which exhibits mutagenic activity.<br>References Peer, R.L., et al.: Enivron. Mutagen., 3, 555 (1981); Macquet, J.P., et al.: Develop. Oncol., 17, 27 (1984); Macquet, J.P., et al.: J. Clin. Hematol. Oncol., 7, 469 (1997);<br></p>Formula:K·Cl3H3NPtColore e forma:NeatPeso molecolare:357.57(3-Chloro-5-propoxyphenyl)boronic acid
CAS:Purezza:95.0%Colore e forma:SolidPeso molecolare:214.4499969482422(4-(Diisopropylcarbamoyl)-2-ethoxypyridin-3-yl)boronic acid
CAS:Purezza:95+%Peso molecolare:294.1600036621094(5,6-Difluoropyridin-3-yl)boronic acid
CAS:Formula:C5H4BF2NO2Purezza:96%Colore e forma:No data available.Peso molecolare:158.9(4-(Decyloxy)phenyl)boronic acid
CAS:Purezza:97.0%Colore e forma:SolidPeso molecolare:278.20001220703125(5-Cyano-1H-indol-2-yl)boronic acid
CAS:Purezza:95.0%Colore e forma:SolidPeso molecolare:185.97999572753906Ref: 10-F447495
1gPrezzo su richiesta100mgPrezzo su richiesta250mgPrezzo su richiesta500mgPrezzo su richiesta(1-(tert-Butoxycarbonyl)-5-(methoxycarbonyl)-1H-indol-2-yl)boronic acid
CAS:Purezza:95.0%Colore e forma:SolidPeso molecolare:319.1199951171875Ref: 10-F213351
1gPrezzo su richiesta2gPrezzo su richiesta5gPrezzo su richiesta100mgPrezzo su richiesta250mgPrezzo su richiesta500mgPrezzo su richiesta(3-(Piperidin-1-yl)phenyl)boronic acid
CAS:Formula:C11H16BNO2Purezza:97%Colore e forma:SolidPeso molecolare:205.06(4-((2-Isopropyl-5-methylphenoxy)methyl)phenyl)boronic acid
CAS:Purezza:96%Peso molecolare:284.1600036621094Iohexol
CAS:Prodotto controllato<p>Applications Imaging agent.<br>References Wolf, G.L., et al.: Invest. Radiol., 16, 320 (1981), Mancini, G.B.J., et al.: Am. J. Cardiol., 51, 1218 (1983), Bettmann, M.A., et al.: Radiology, 153, 583 (1984), Sullivan, I.D., et al.: Br. Heart J.,51, 643 (1984),<br></p>Formula:C19H26I3N3O9Colore e forma:Off-WhitePeso molecolare:821.145-Amino-2,4,6-triiodoisophthalic Acid
CAS:Prodotto controllato<p>Impurity Iohexol EP Impurity K<br>Applications 5-Amino-2,4,6-triiodoisophthalic Acid (Iohexol EP Impurity K) is an intermediate for nonionic iodinated X-ray contrast agents.<br></p>Formula:C8H4I3NO4Colore e forma:NeatPeso molecolare:558.84N-Acetyl Cyclized Iodixanol
CAS:Prodotto controllato<p>Stability Hygroscopic<br>Applications N-Acetyl Cyclized Iodixanol is an impurity of Iodixanol (I667200) which is a nonionic, dimeric x-ray contrast medium.<br>References Svaland, M.G., et al.: Invest. Radiol., 27, 130 (1992), Palmers, Y., et al.: Eur. J. Radiol., 17, 203 (1993), Conroy, R.M., et al.: Clin. Radiol., 49, 337 (1994)<br></p>Formula:C35H43I5N6O15Colore e forma:NeatPeso molecolare:1422.27(2-Fluoro-5-((4-methylpiperazin-1-yl)methyl)phenyl)boronic acid
CAS:Purezza:98%Peso molecolare:252.10000610351562Oxaliplatin
CAS:Prodotto controllato<p>Applications Third generation platinum complex. An antitumor agent with activity against colorectal cancer. Cytotoxicity follows the formation of adducts with DNA. Antineoplastic.<br>References Kidani, Y., et al.: J. Med. Chem., 21, 1315 (1978), Kizu, R., et al.: Cancer Chemother. Pharmacol., 31, 475 (1993), Levi, F., et al.: Eur. J. Cancer, 29A, 1280 (1993), Simpson, D., et al.: Drugs, 63, 2127 (2003),<br></p>Formula:C8H14N2O4PtColore e forma:White To Off-WhitePeso molecolare:397.29Ref: 10-F694034
1gPrezzo su richiesta100mgPrezzo su richiesta250mgPrezzo su richiesta500mgPrezzo su richiesta(3-((4-Chlorophenoxy)methyl)phenyl)boronic acid
CAS:Formula:C13H12BClO3Purezza:95.0%Colore e forma:SolidPeso molecolare:262.5(S,S)-Oxaliplatin
CAS:Prodotto controllato<p>Applications The (S,S) Oxaliplatin isomer. Third generation platinum complex. An antitumor agent with activity against colorectal cancer. Cytotoxicity follows the formation of adducts with DNA. Antineoplastic.<br>References Kidani, Y., et al.: J. Med. Chem., 21, 1315 (1978), Kizu, R., et al.: Cancer Chemother. Pharmacol., 31, 475 (1993), Levi, F., et al.: Eur. J. Cancer, 29A, 1280 (1993), Simpson, D., et al.: Drugs, 63, 2127 (2003),<br></p>Formula:C8H14N2O4PtColore e forma:WhitePeso molecolare:397.29N,N’-Bis(2,3-dihydroxypropyl)-5-nitro-1,3-benzenedicarboxamide
CAS:Prodotto controllato<p>Impurity Iohexol USP Related Compound C<br>Applications N,N'-Bis(2,3-dihydroxypropyl)-5-nitro-1,3-benzenedicarboxamide is used in the preparation of X-ray contrast agents.<br>References Haavaldsen, J. et al.: Acta Pharmac. Sue., 20, 219 (1983);<br></p>Formula:C14H19N3O8Colore e forma:White To Off-WhitePeso molecolare:357.32N1-(3-(2,3-Dihydroxypropoxy)-2-hydroxypropyl) Iohexol
CAS:Prodotto controllato<p>Impurity Iohexol EP Impurity D<br>Applications N1-(3-(2,3-dihydroxypropoxy)-2-hydroxypropyl) Iohexol is an impurity of Iohexol (I729500), Imaging agent.<br>References Wolf, G.L., et al.: Invest. Radiol., 16, 320 (1981), Mancini, G.B.J., et al.: Am. J. Cardiol., 51, 1218 (1983), Bettmann, M.A., et al.: Radiology, 153, 583 (1984), Sullivan, I.D., et al.: Br. Heart J.,51, 643 (1984),<br></p>Formula:C22H32I3N3O11Colore e forma:Off-WhitePeso molecolare:895.22Gadoteric Acid
CAS:Prodotto controllato<p>Applications Gadoteric Acid is used for magnetic resonance imaging.<br>References Gheuens, E., et al.: Invest. Radiol., 49, 505-508 (2014)<br></p>Formula:C16H25GdN4O8Colore e forma:White To Off-WhitePeso molecolare:558.64DOTA
CAS:Prodotto controllato<p>Stability Hygroscopic<br>Applications Bifunctional DOTA conjugates to peptides and has become an established strategy for constructing target-specific metal containing agents including targeted MRI contrast agents and diagnostic and therapeutic radiopharmaceuticals.<br>References Lewis, M., et al.: Bioconjug. Chem., 9, 72 (1998), Chappell, L., et al.: Bioorg. Med. Chem., 7, 2313 (1999), Prantner, A., et al.: Mol. Imaging, 2, 333 (2003), Allen, M., et al.: Chem. Biol., 11, 301 (2004), Weiner, R., et al.: BioDrugs, 19, 145 (2005), Breeman, W., et al.: Radionuclide Peptide Cancer Therapy, 119 (2006),<br></p>Formula:C16H28N4O8Colore e forma:Light YellowPeso molecolare:404.42N1-(2-(2,3-Dihydroxypropoxy)-3-hydroxypropyl Iohexol
CAS:<p>Impurity Iohexol EP Impurity E<br>Applications N1-(2-(2,3-dihydroxypropoxy)-3-hydroxypropyl) Iohexol is an impurity of Iohexol (I729500), Imaging agent.<br>References Wolf, G.L., et al.: Invest. Radiol., 16, 320 (1981), Mancini, G.B.J., et al.: Am. J. Cardiol., 51, 1218 (1983), Bettmann, M.A., et al.: Radiology, 153, 583 (1984), Sullivan, I.D., et al.: Br. Heart J.,51, 643 (1984),<br></p>Formula:C22H32I3N3O11Colore e forma:NeatPeso molecolare:895.22Caldiamide Sodium
CAS:Prodotto controllato<p>Stability Hygroscopic<br>Applications Caldiamide Sodium is an analog of Gadodiamide (G125710) which is an apoptosis inducing agent used in chondrocytes. Gadodiamide is primarily used in muscoskeletal diagnosis as a contrast agent.<br>References Greisberg, J. et al.: Mag. Res. Imag., 19, 731 (2001); Hemmingsson, A. et al.: Mag. Res. Mat. Phys. Biol. Med., 12, 96 (2001)<br></p>Formula:C16H26CaN5NaO8Colore e forma:NeatPeso molecolare:479.482-Fluoro-3-methoxyphenylboronic acid
CAS:Prodotto controllato<p>Applications 2-Fluoro-3-methoxyphenylboronic acid<br></p>Formula:C7H8BFO3Colore e forma:NeatPeso molecolare:169.95Carboplatin
CAS:<p>Applications Analog of Cisplatin with reduced nephrotoxicity. Antineoplastic.<br>References Harland, S.J., et al.: Cancer Res., 44, 1693 (1984), Smith, I.E., et al.: Cancer Treat. Rep., 69, 43 (1985), Lygidakis, N.J., et al.: Interferon Cytokine Res., 15, 467 (1995),<br></p>Formula:C6H12N2O4PtColore e forma:White To Off-WhitePeso molecolare:371.25(1-(Tetrahydrofuran-3-yl)-1H-pyrazol-4-yl)boronic acid
CAS:Purezza:98%Peso molecolare:181.99000549316406Des(2-Hydroxypropyl) Gadoteridol
CAS:Prodotto controllato<p>Stability Hygroscopic<br>Applications Des(2-hydroxypropyl) Gadoteridol is a contrast imaging agent metabolite from Gadoteridol (G125900), used as an MRI contrast chelating agent.<br>References Filippi, M. et al.: Chem. Comm., 50, 3453 (2014); Ferrauto, G. et al.: J. Am. Chem. Soc., 136, 638 (2014);<br></p>Formula:C14H23GdN4O6Colore e forma:NeatPeso molecolare:500.61Iohexol-D5
CAS:Prodotto controllato<p>Stability Hygroscopic<br>Applications Deuterated Iohexol. Imaging agent.<br>References Wolf, G.L., et al.: Invest. Radiol., 16, 320 (1981), Mancini, G.B.J., et al.: Am. J. Cardiol., 51, 1218 (1983), Bettmann, M.A., et al.: Radiology, 153, 583 (1984), Sullivan, I.D., et al.: Br. Heart J.,51, 643 (1984),<br></p>Formula:C19H21D5I3N3O9Colore e forma:NeatPeso molecolare:826.175-Amino-N,N’-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide
CAS:Prodotto controllato<p>Stability Hygroscopic<br>Applications Used as an intermediate in the industrial preparation of non-ionic X-ray contrast agents such as Iohexol (I729500), Ioversol (I737000), Ioxilan (I737500), Iopamidol (I735600).<br>References Rongved, P., et al.: Carbohydrate Res., 297, 325 (1997),<br></p>Formula:C14H18I3N3O6Colore e forma:NeatPeso molecolare:705.02Gadopentetic Acid
CAS:Prodotto controllato<p>Applications: Gadopentetic Acid is a magnetic resonance contrast agent being used to develop a new platform for the delivery of therapeutic and imaging agents simultaneously to the colon.<br>References Jin, M., et al.: Mol. Pharm, 13, 2457-2465 (2016)<br></p>Formula:C14H20GdN3O10Colore e forma:NeatPeso molecolare:547.57Diaquo[(1R,2R)-1,2-cyclohexanediamine]platinum Dimer Dinitrate
CAS:Prodotto controllato<p>Impurity Oxaliplatin EP Impurity E<br>Stability Light Sensitive<br>Applications A dimeric impurity of Oxaliplatin (O845075) with neoplasm-inhibiting activity.<br>References Gill, D.: Dev. Oncol., 17, 267 (1984);<br></p>Formula:C12H30N6O8Pt2Colore e forma:White To Light YellowPeso molecolare:776.56Cyclic Iodixanol (90%)
CAS:Prodotto controllato<p>Stability Hygroscopic<br>Applications Cyclic Iodixanol is an impurity of Iodixanol (I667200) which is a nonionic, dimeric x-ray contrast medium.<br>References Svaland, M.G., et al.: Invest. Radiol., 27, 130 (1992), Palmers, Y., et al.: Eur. J. Radiol., 17, 203 (1993), Conroy, R.M., et al.: Clin. Radiol., 49, 337 (1994)<br></p>Formula:C33H41I5N6O14Purezza:90%Colore e forma:NeatPeso molecolare:1380.23
![{1-[(tert-Butoxy)carbonyl]-1,2,5,6-tetrahydropyridin-3-yl}boronic acid](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF625887.webp&w=3840&q=75)
![Diaquo[(1R,2R)-1,2-cyclohexanediamine]platinum Dimer Dinitrate](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FD416765.webp&w=3840&q=75)
